WDR62在肝细胞肝癌中的表达及预后价值OA
Expression and Prognostic Value of WDR62 in Hepatocellular Carcinoma
目的 探讨WDR62在肝细胞肝癌(hepatocellular carcinoma,HCC)中的表达特征及其与临床病理特征和预后的关系,并基于WDR62构建总生存(overall survival,OS)预测列线图模型.方法 利用癌症基因组图谱(the cancer genome atlas,TCGA)肝细胞肝癌队列(TCGA-LIHC)RNA-seq及临床资料,比较癌与癌旁WDR62 mRNA表达差异,并通过受试者工作特征(receiver operating characteristic,ROC)曲线评估其诊断价值.按WDR62表达中位数分为高、低表达组,分析其与临床病理特征及OS、生存结局[肿瘤特异性生存(disease-specific survival,DSS)、无进展生存(progression-free survival,PFS)]的关系.采用单因素和多因素Cox回归筛选OS独立危险因素,在此基础上构建预后列线图;通过Harrell C指数(Harrell's concordance index,C-index)、校准曲线和决策曲线分析(decision curve analysis,DCA)评价模型性能.另收集昆明医科大学第二附属医院配对手术标本,行免疫组织化学(immunohistochemistry,IHC)检测WDR62蛋白表达.结果 TCGA-LIHC共纳入HCC 424例及癌旁组织50例,WDR62在HCC中表达显著升高(P<0.001),区分癌与癌旁的曲线下面积(area under the curve,AUC)为 0.964.WDR62 高表达组病理Ⅲ~Ⅳ期、组织学 G3~G4、甲胎蛋白(alpha-fetoprotein,AFP)>400 ng/mL及有肿瘤状态患者比例升高,OS死亡事件更多(P<0.05).Kaplan-Meier分析显示,高表达组OS、DSS和PFS均明显低于低表达组(OS:P=0.004).多因素Cox分析表明,病理T3~T4期、有肿瘤状态及WDR62高表达是OS的独立危险因素,其中WDR62高表达风险比(hazard ratio,HR)为1.656(95%置信区间confidence interval,CI:1.028~2.667,P=0.038).列线图模型 Harrell C-index 为 0.629(95%CI:0.576~0.680),1、3、5年OS校准良好,DCA显示在约0.05~0.20阈值概率范围内模型具有较高净获益.该院IHC队列中,HCC组织WDR62蛋白表达亦高于癌旁(P<0.05).结论 WDR62在HCC中高表达并与肿瘤进展及不良预后相关.基于WDR62及临床病理特征构建的OS预后列线图在TCGA-LIHC队列中具有一定预测能力.
Objective To investigate the expression pattern of WD repeat-containing protein 62(WDR62)in hepatocellular carcinoma(HCC),its association with clinicopathological features and prognosis,and to construct a prognostic nomogram model for overall survival(OS)based on WDR62.Methods RNA sequencing data and clinical information for HCC were obtained from The Cancer Genome Atlas Liver Hepatocellular Carcinoma cohort(TCGA-LIHC).WDR62 messenger RNA(mRNA)expression was compared between tumor and adjacent non-tumor liver tissues.Its diagnostic value was assessed using receiver operating characteristic(ROC)curves.Patients were divided into high-and low-expression groups according to the median WDR62 expression level.Associations between WDR62 expression and clinicopathological variables,as well as survival outcomes including OS,disease-specific survival(DSS)and progression-free survival(PFS)were analyzed.Univariate and multivariate Cox proportional hazards regression analyses were performed to identify independent prognostic factors for OS.Subsequently,a prognostic nomogram was constructed.Harrell's concordance index(C-index),calibration curves and decision curve analysis(DC A)were used to assess model performance.In addition,paired HCC and adjacent liver tissues from surgical specimens in our hospital were collected from the Second Affiliated Hospital of Kunming Medical University,and WDR62 protein expression was examined by immunohistochemistry(IHC).Results A total of 424 HCC cases and 50 adjacent/normal liver tissues samples from TCGA-LIHC were included.WDR62 mRNA expression was significantly higher in HCC tissues than in adjacent tissues(P<0.001),with an area under the ROC curve(AUC)of 0.964 for distinguishing HCC from adjacent/normal tissues.The high WDR62 expression group exhibited higher proportions of patients with pathological stage Ⅲ-Ⅳ,histologic grade G3-G4,alpha-fetoprotein(AFP)>400 ng/mL and the presence of tumor status,and a higher incidence of OS events(P<0.05).Kaplan-Meier curves showed significantly poorer OS,DSS and PFS in the high-expression group(OS:P=0.004).Multivariate Cox analysis identified pathological T3~T4 stage,presence of tumor status and high WDR62 expression as independent risk factors for OS;high WDR62 expression had a hazard ratio(HR)of 1.656(95%confidence interval[CI]:1.028~2.667,P=0.038).The nomogram model achieved a Harrell's C-index of 0.629(95%CI:0.576~0.680).Calibration curves for 1-,3-and 5-year OS showed good agreement,and DCA indicated that the model provided higher net benefit within a threshold probability range of approximately 0.05~0.20.In the hospital IHC cohort,WDR62 protein expression was also significantly higher in HCC tissues than in paired adjacent tissues(P<0.05).Conclusion WDR62 is up-regulated in HCC and is closely associated with tumor progression and poor prognosis.The OS prognostic nomogram constructed based on WDR62 and clinicopathological variables shows acceptable predictive capability within the TCGA-LIHC cohort.
张富伟;王滔;吴涛
昆明医科大学第二附属医院肝胆科,云南 昆明 650101昆明医科大学第二附属医院肝胆科,云南 昆明 650101昆明医科大学第二附属医院肝胆科,云南 昆明 650101
医药卫生
肝细胞肝癌WDR62免疫组织化学生存分析
Hepatocellular carcinomaWDR62ImmunohistochemistrySurvival analysis
《昆明医科大学学报》 2026 (3)
12-22,11
国家自然科学基金(8236058982360137)云南省人社厅-云南省"兴滇英才支持计划"-云南省肝胆胰外科微创治疗团队(202305AS350033)云南省卫健委-院士(专家)工作站项目-云南省虞先濬专家工作站(202205AF150127)云南省科技厅-昆明医科大学应用基础研究联合专项基金(202301AY070001-269)
评论